Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
September 2012 Volume 30 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September 2012 Volume 30 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrPSc

  • Authors:
    • Han-Shi Gong
    • Yan Guo
    • Chan Tian
    • Wu-Ling Xie
    • Qi Shi
    • Jin Zhang
    • Yin Xu
    • Shao-Bin Wang
    • Bao-Yun Zhang
    • Cao Chen
    • Yong Liu
    • Xiao-Ping Dong
  • View Affiliations / Copyright

    Affiliations: School of Medicine, Xi'an Jiao Tong University, Xi'an 710061, P.R. China, State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, P.R. China
  • Pages: 569-578
    |
    Published online on: June 12, 2012
       https://doi.org/10.3892/ijmm.2012.1025
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Microtubule affinity-regulating kinase 4 (MARK4) belongs to a family of kinases that are able to actively phosphorylate the neuronal microtubule-associate proteins (MAPs), such as tau, MAP2 and the ubiquitous MAP4. Abnormal changes in tubulin and the profiles of tau have been previously reported in the human brain and animal transmissible spongiform encephalopathies (TSEs), which may be associated with abnormal alterations of various cellular kinases. To elucidate the possible role of MARK4 in TSE pathogenesis, the MARK4 levels in the brain tissues of scrapie-infected rodents and human prion diseases were evaluated using western blotting and immunohistochemical assays. The results revealed that at terminal stages of the diseases, MARK4 levels in the brain tissues of the scrapie 263K-infected hamsters, 139A-infected mice and a case of Creutzfeldt-Jakob disease (CJD, G114V gCJD) correlated with amounts of PrPSc deposits that were almost undetectable. On the other hand MARK4 signals were noticeable in the brain tissues of a fatal familial insomnia (FFI) patient without PrPSc. The reduction of MARK4 was closely related to the prolonged incubation times. These results could be reproduced in SK-N-SH and PC12 cell lines after being exposed to the synthetic peptide PrP106-126. Accordingly, the levels of phosphorylated tau at Ser262 (p-tau262) in cultured cells exposed to PrP106-126, or the ratios of p-tau262/total tau in the brain tissues of 263K-infected hamsters were also significantly decreased. According to our data there is a correlation between a TSE pathological-associated decline of MARK4 in the brain tissues with the deposits of PrPSc. Reduction of MARK4 will result in abnormalities of tau phosphorylation, and possibly induce further detachment of microtubules and hinder microtubule transportation.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1. 

SB PrusinerPrionsProc Natl Acad Sci USA951336313383199810.1073/pnas.95.23.133639811807

2. 

B CaugheyB ChesebroPrion protein and the transmissible spongiform encephalopathiesTrends Cell Biol75662199710.1016/S0962-8924(96)10054-417708907

3. 

J CastillaP SaaC HetzC SotoIn vitro generation of infectious scrapie prionsCell121195206200510.1016/j.cell.2005.02.01115851027

4. 

G LegnameIV BaskakovHO NguyenSynthetic mammalian prionsScience305673676200410.1126/science.1100195

5. 

MP McKinleyDC BoltonSB PrusinerA protease-resistant protein is a structural component of the scrapie prionCell355762198310.1016/0092-8674(83)90207-66414721

6. 

A DesaiTJ MitchisonMicrotubule polymerization dynamicsAnnu Rev Cell Dev Biol1383117199710.1146/annurev.cellbio.13.1.83

7. 

GG GundersenEvolutionary conservation of microtubule-capture mechanismsNat Rev Mol Cell Biol3296304200210.1038/nrm77711994749

8. 

GR WangS ShiC GaoChanges of tau profiles in brains of the hamsters infected with scrapie strains 263 K or 139 A possibly associated with the alteration of phosphate kinasesBMC Infect Dis1086201010.1186/1471-2334-10-8620356412

9. 

CF DongS ShiXF WangThe N-terminus of PrP is responsible for interacting with tubulin and fCJD related PrP mutants possess stronger inhibitive effect on microtubule assembly in vitroArch Biochem Biophys4708392200810.1016/j.abb.2007.11.00718037369

10. 

XL LiGR WangYY JingCytosolic PrP induces apoptosis of cell by disrupting microtubule assemblyJ Mol Neurosci43316325201110.1007/s12031-010-9443-920838930

11. 

B TrinczekM BrajenovicA EbnethG DrewesMARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomesJ Biol Chem27959155923200410.1074/jbc.M304528200

12. 

T KatoS SatohH OkabeIsolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesisNeoplasia349200110.1038/sj.neo.790013211326310

13. 

A SchneiderR LaageO von AhsenIdentification of regulated genes during permanent focal cerebral ischaemia: characterization of the protein kinase 9b5/MARKL1/MARK4J Neurochem8811141126200410.1046/j.1471-4159.2003.02228.x

14. 

A BeghiniI MagnaniG RoversiThe neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell linesOncogene2225812591200310.1038/sj.onc.120633612735302

15. 

M HasegawaM Morishima-KawashimaK TakioM SuzukiK TitaniY IharaProtein sequence and mass spectrometric analyses of tau in the Alzheimer’s disease brainJ Biol Chem26717047170541992

16. 

EM MandelkowE ThiesB TrinczekJ BiernatE MandelkowMARK/PAR1 kinase is a regulator of microtubule-dependent transport in axonsJ Cell Biol16799110200410.1083/jcb.20040108515466480

17. 

J ZhangL ChenBY ZhangComparison study on clinical and neuropathological characteristics of hamsters inoculated with scrapie strain 263K in different challenging pathwaysBiomed Environ Sci1765782004

18. 

YS KimRI CarpSM CallahanHM WisniewskiIncubation periods and survival times for mice injected stereotaxically with three scrapie strains in different brain regionsJ Gen Virol68695702198710.1099/0022-1317-68-3-6953546594

19. 

J YeJ HanQ ShiHuman prion disease with a G114V mutation and epidemiological studies in a Chinese family: a case seriesJ Med Case Rep2331200810.1186/1752-1947-2-33118925969

20. 

Q ShiBY ZhangC GaoJ HanGR WangC ChenC TianXP DongThe pathological and pathogenic characteristics in various brain regions from a Chinese patient with G114V genetic CJDNeuropathology325159201210.1111/j.1440-1789.2011.01237.x21732990

21. 

XH ShiJ HanJ ZhangClinical, histopathological and genetic studies in a family with fatal familial insomniaInfect Genet Evol10292297201010.1016/j.meegid.2010.01.00720096809

22. 

JM ChenC GaoQ ShiDifferent expression patterns of CK2 subunits in the brains of experimental animals and patients with transmissible spongiform encephalopathiesArch Virol15310131020200810.1007/s00705-008-0084-z

23. 

G ForloniN AngerettiR ChiesaNeurotoxicity of a prion protein fragmentNature362543546199310.1038/362543a08464494

24. 

T FlorioS ThellungC AmicoPrion protein fragment 106–126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell lineJ Neurosci Res543413521998

25. 

M EttaicheR PichotJP VincentJ ChabryIn vivo cytotoxicity of the prion protein fragment 106–126J Biol Chem27536487364902000

26. 

G DrewesB TrinczekS IllenbergerMicrotubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262J Biol Chem270767976881995

27. 

G ManningDB WhyteR MartinezT HunterS SudarsanamThe protein kinase complement of the human genomeScience29819121934200210.1126/science.107576212471243

28. 

RF MoroniS De BiasiP ColapietroL LarizzaA BeghiniDistinct expression pattern of microtubule-associated protein/microtubule affinity-regulating kinase 4 in differentiated neuronsNeuroscience1438394200610.1016/j.neuroscience.2006.07.052

29. 

F TagliaviniF PrelliL VergaSynthetic peptides homologous to prion protein residues 106–147 form amyloid-like fibrils in vitroProc Natl Acad Sci USA90967896821993

30. 

YH LiuYL HanJ SongHeat shock protein 104 inhibited the fibrillization of prion peptide 106–126 and disassembled prion peptide 106–126 fibrils in vitroInt J Biochem Cell Biol43768774201121296677

31. 

I MagnaniC NovielliM BelliniG RoversiL BelloL LarizzaMultiple localization of endogenous MARK4L protein in human gliomaCell Oncol31357370200919759416

32. 

RD TerryThe pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesisJ Neuropathol Exp Neurol5510231025199610.1097/00005072-199655100-000018857998

33. 

EM MandelkowJ BiernatG DrewesN GustkeB TrinczekE MandelkowTau domains, phosphorylation, and interactions with microtubulesNeurobiol Aging16355363199510.1016/0197-4580(95)00025-A7566345

34. 

M ZunguJC SchislerMF EssopC McCuddenC PattersonMS WillisRegulation of AMPK by the ubiquitin proteasome systemAm J Pathol178411201110.1016/j.ajpath.2010.11.03021224036

35. 

AK Al-HakimA ZagorskaL ChapmanM DeakM PeggieDR AlessiControl of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chainsBiochem J411249260200810.1042/BJ2008006718254724

36. 

J SatohS ObayashiT MisawaK SumiyoshiK OosumiH TabunokiProtein microarray analysis identifies human cellular prion protein interactorsNeuropathol Appl Neurobiol351635200910.1111/j.1365-2990.2008.00947.x18482256

37. 

K StamerR VogelE ThiesE MandelkowEM MandelkowTau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stressJ Cell Biol15610511063200210.1083/jcb.20010805711901170

38. 

A EbnethR GodemannK StamerS IllenbergerB TrinczekE MandelkowOverexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer’s diseaseJ Cell Biol14377779419989813097

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Gong H, Guo Y, Tian C, Xie W, Shi Q, Zhang J, Xu Y, Wang S, Zhang B, Chen C, Chen C, et al: Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrPSc. Int J Mol Med 30: 569-578, 2012.
APA
Gong, H., Guo, Y., Tian, C., Xie, W., Shi, Q., Zhang, J. ... Dong, X. (2012). Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrPSc. International Journal of Molecular Medicine, 30, 569-578. https://doi.org/10.3892/ijmm.2012.1025
MLA
Gong, H., Guo, Y., Tian, C., Xie, W., Shi, Q., Zhang, J., Xu, Y., Wang, S., Zhang, B., Chen, C., Liu, Y., Dong, X."Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrPSc". International Journal of Molecular Medicine 30.3 (2012): 569-578.
Chicago
Gong, H., Guo, Y., Tian, C., Xie, W., Shi, Q., Zhang, J., Xu, Y., Wang, S., Zhang, B., Chen, C., Liu, Y., Dong, X."Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrPSc". International Journal of Molecular Medicine 30, no. 3 (2012): 569-578. https://doi.org/10.3892/ijmm.2012.1025
Copy and paste a formatted citation
x
Spandidos Publications style
Gong H, Guo Y, Tian C, Xie W, Shi Q, Zhang J, Xu Y, Wang S, Zhang B, Chen C, Chen C, et al: Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrPSc. Int J Mol Med 30: 569-578, 2012.
APA
Gong, H., Guo, Y., Tian, C., Xie, W., Shi, Q., Zhang, J. ... Dong, X. (2012). Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrPSc. International Journal of Molecular Medicine, 30, 569-578. https://doi.org/10.3892/ijmm.2012.1025
MLA
Gong, H., Guo, Y., Tian, C., Xie, W., Shi, Q., Zhang, J., Xu, Y., Wang, S., Zhang, B., Chen, C., Liu, Y., Dong, X."Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrPSc". International Journal of Molecular Medicine 30.3 (2012): 569-578.
Chicago
Gong, H., Guo, Y., Tian, C., Xie, W., Shi, Q., Zhang, J., Xu, Y., Wang, S., Zhang, B., Chen, C., Liu, Y., Dong, X."Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrPSc". International Journal of Molecular Medicine 30, no. 3 (2012): 569-578. https://doi.org/10.3892/ijmm.2012.1025
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team